Terapia con medicamentos para la diarrea

Marion Debus

Última actualización: 30.05.2022

  • En diarrea:
    Birkenkohle comp. Caps. WELEDA o Carbo Betulae comp. WELEDA  CH, 2 caps. por vaciamiento intestinal o 3 x día hasta 1 x hora
    o
    Bolus alba comp. Polvo WALA 1–3 cucharaditas de té x día siempre en 200 ml de líquido
  • En diarrea y vómitos:
    Bolus alba comp. Polvo WALA 1 pizca por hora  

  • En daño de la mucosa del duodeno por quimioterapia o tratamiento con rayos:
    Digestodoron® WELEDA 2 x día masticar 2 tabletas al comienzo de las comidas o 4 x día 15 gotas
    o
    Añadir, para activarla función desintoxicante renal y hepática bajo quimioterapia:
    Aquilinum comp. glób. velati WALA 3 x día 7–10 glób. o 1 x día 1 amp. oral
  • En daño de la mucosa debido a la radioterapia:
    Stibium arsenicosum D6 trit. WELEDA 3 x día una pizca
    o
    En diarreas especialmente mucosas:
    Geum urbanum D1 WELEDA 3–6 x día 10 gotas
  • En enterocolitis con diarreas mucosas y alta pérdida de líquido:
    Quarzo en polvo 50% WELEDA 5 x día ¼ de cucharadita con un poco de líquido

  • En diarreas incoercibles post trasplante medular:
    Luvos Heilerde magenfein 3 x día 1 cucharadita de té

  • Diarrea durante la radioterapia rectal adyuvante en carcinoma del recto. En el tercio final del tratamiento por regla general se presentan síntomas de irritación y diarreas.
    Local: ungüento WALA y Mercurialis comp. Sup. WALA
    o
    Bolus alba comp. Polvo WALA
    Stibium arsenicosum D6 trit. WELEDA 3 x día 1 pizca
    Geum urbanum D1 WELEDA 3–6 x día 10 gotas

Research news

Non-pharmacological interventions with good clinical evidence for chemotherapy-induced neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is the most common side effect for oncology patients. Therefore, their interest in complementary non-pharmacological therapies is high. A current scoping review presents the clinical evidence of therapies used in this context. Relevent studies published between 2000 and 2021 were analyzed. The panel of authors identified 17 supportive interventions, which they included in their assessment. Most were phytotherapeutic interventions including external applications and cryotherapy, hydrotherapy, and tactile stimulation. More than two-thirds of the consented interventions were rated with moderate to high perceived clinical effectiveness in therapeutic use. Therefore, the experts endorse these complementary procedures for the supportive treatment of CIPN. The review is available at: 
https://doi.org/10.3390/medsci11010015.